Inbound travellers and members of the public who recently visited the Middle East and developed fever or lower respiratory symptoms within 14 days will be classified as suspected MERS
Evidence for camel-to-human transmission of MERS
virus was first identified in Saudi Arabia in 2012 and has so far claimed 400 lives.
However, the Saudi government has declared zero MERS
infection among the Hajj pilgrims for the past three years.
The protein, an antibody named LCA60, seems to latch onto the MERS
virus, preventing it from infecting a cell.
He was transferred immediately to the RITM when tests yielded positive for MERS
Three years after the MERS
virus first emerged in humans, there is no cure or vaccine that can protect people from falling sick with it, and little work has been done in develop a vaccine, despite considerable available scientific detail.
As no treatment is available for the disease, approximately 36 per cent of the reported patients with MERS
At its peak in April-May 2014, the World Health Organization (WHO) was considering declaring MERS
a public health emergency.
Health care providers and health departments throughout the United States should continue to consider a diagnosis of MERS
-CoV infection in persons who develop fever and respiratory symptoms within 14 days after traveling from countries in or near the Arabian Peninsula, and be prepared to detect and manage cases of MERS
Best clinical practices for preventing the spread of MERS
Iran has confirmed the country's first two cases and first death from MERS
, a deadly virus that first erupted two years ago in Saudi Arabia.